Needle-free Injection System Market Analysis Report, Regional Outlook with Key Players – Antares Pharma, Portal Instruments, PharmaJet, Bioject Medical Technologies, Medical International Technology, PenJet, INJEX Pharma AG, National Medical Products, E

Coherent Market Insights has announced the addition of the “Needle-free Injection System Market Size Status and Forecast 2026”, The report classifies the global Needle-free Injection System Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.

This report studies the global Needle-free Injection System Speaker market, analyzes and researches the Needle-free Injection System Speaker development status and forecast in North America, Europe, Asia Pacific, Latin America and Rest of the World. This report focuses on the top players in global market, like
Antares Pharma, Portal Instruments, PharmaJet, Bioject Medical Technologies, Medical International Technology, PenJet, INJEX Pharma AG, National Medical Products, European Pharma

Request a sample copy : https://www.coherentmarketinsights.com/insight/request-sample/1681

Needle-free injection system is continuously expanding its market footprint on account of various factors. Increasing incidence of needle associated injuries and needle phobia amongst children and adults is expected to drive growth of needle-free injection system market. According to a study published in Behavioral Neurology, 2014, around 3-4 % of the world population faces needle phobia. This impacts their hospital or clinic visits, as they avoid visiting such facilities due to fear of exposure to needles. Needle phobia also impacts the vaccination amongst children, as most of them perceives injecting vaccine as a painful procedure. According to a study published in the Clinical Journal of Pain in 2015, there were 12 billion vaccination every year worldwide, most of which required injecting drug with a needle syringe system. Increasing demand for vaccines and other biologic products is another factor boosting growth of the needle-free injection system market.

Chronic disease such as diabetes often needs daily dose of insulin, which has to be administered through pain needles. This may lead to lack of adherence to treatment due to lack of confidence to self-inject insulin. Increasing research on biologics and biosimilar is another factor expected to fuel growth of the market. Biologicals are increasingly launched and prescribed to treat disease such as GI tract disease (ulcerative colitis and Crohn’s disease), central nervous system associated disease (multiple sclerosis and Alzheimer’s disease), and cancer. Other factors such as increasing incidence of communicable diseases caused due to conventional needle, increasing geriatric population worldwide who need palliative care, and growing awareness about safe injection practices are also expected to drive growth of needle-free injection system market.

On the basis of product type:

Prefilled
Fillable

On the basis of delivery site:

Subcutaneous Injectors
Intramuscular Injectors
Intradermal Injectors

On the basis of product lifecycle:

Disposable
Reusable

On the basis of technology:

Jet-based needle free injector
Spring-based needle free injector
Laser-powered needle free injector

On the basis of application:

Vaccine and other biologic product delivery
Insulin Delivery
Others

On the basis of end user:

Hospitals & Clinics
Home based care

On the basis of geography:

North America
Latin America
Europe
Asia Pacific
Middle East
Africa

North America is a dominant region in the global needle-free injection system market. This is due to high prevalence of chronic diseases such as diabetes and cancer. According to the American Cancer Society, 2018, cancer is the second leading cause of death after cardio vascular disease in the U.S. Furthermore, around 1.7 million new cancer cases were reported by 2017 in this region. Rising number of biologic drug approval in the U.S. is another factor driving growth of needle-free injection system market. Asia Pacific is witnessing high growth in the needle-free injection system market, as vaccine need is highest in this region. Moreover, this region has high prevalence of lifestyle disease such as diabetes.

Collaborations amongst companies to develop the needle-free injection system would also boost growth of needle-free injection system market. For instance, in November 2017, Takeda Pharmaceutical and Portal Instruments entered into collaboration agreement to develop the needle-free drug delivery device with the Takeda Pharmaceuticals biologic medicines for hepatitis, Crohn's disease etc.

Else place an Inquire before Purchase “Needle-free Injection System Market Size, Status and Forecast 2026 : https://www.coherentmarketinsights.com/insight/talk-to-analyst/1681

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.